临床试验/NCT00622596

NCT00622596已完成不适用

Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance

Yale University2 个研究点分布在 1 个国家目标入组 200 人开始时间: 2003年10月最近更新: 2016年8月24日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: Yale University
入组人数: 200
试验地点: 2
主要终点: Opioid free urine toxicology

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this study was to expand access to buprenorphine using a mobile health care system among marginalized populations with or at high risk for HIV and observe longitudinal effects of treatment.

研究设计

研究类型: Interventional
分配方式: Na
干预模型: Single Group
主要目的: Treatment
盲法: None

入排标准

年龄范围: 18 Years 至 75 Years（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•At high risk for HIV (IV drug use, commercial sex worker, partner of HIV+)
•Mental Health (unmanaged or diagnosed mental illness)

排除标准

•Benzodiazepine use
•Opiate use due to pain management issues only (present or past)

结局指标

主要结局

Opioid free urine toxicology

时间窗: 10/1/03-9/30/08

To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using incidence of opioid free urine toxicology.

Attendance

时间窗: 10/1/03-9/30/08

To assess the feasibility and efficacy of the use of buprenorphine to treat opioid dependence in high risk populations accessing a mobile health care system using tracked attendance.

次要结局

Access to other health care, incarceration, hospitalization acceptability of the site of care from both patient and provider perspectives, and attendance and adherence to counseling.(10/1/03-9/30/08)

研究者

发起方

Yale University

申办方类型

Other

责任方

Sponsor

研究点 (2)

Loading locations...

相似试验

已完成

不适用

Buprenorphine Treatment Engagement and Overdose PreventionOpioid-use Disorder

NCT03677986Johns Hopkins University41

已完成

不适用

Providing PrEP, Hepatitis C Treatment, and MOUD Through Telemedicine at Greensboro SSPOpioid UseOpioid Use DisorderRisk ReductionHivHepatitis C

NCT05108935Duke University17

已完成

不适用

MySafeRx & MedicaSafe Open-Label Buprenorphine Induction and Lapse Evaluation (MyMOBILE)Opioid Use Disorder

NCT02942199Cambridge Health Alliance12

终止

2 期

Buprenorphine as Adjunct to Outpatient Induction Onto VivitrolOpioid-use Disorder

NCT03113409New York State Psychiatric Institute10

已完成

1 期

Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-ReleaseOpiate Addiction

NCT00367302National Development and Research Institutes, Inc.116